Health

Shaping Global Health Governance: From Innovation to Impact

In an era of fragmenting geopolitical coordination and declining public funding, the private sector must step up as a market shaper and a partner in governance. We enable pharmaceutical companies, biotechs, and foundations to navigate the complex ecosystems of Geneva, Brussels, and Washington to drive systemic change.

Strategic Context: The New Health Diplomacy

Healthcare systems worldwide face increasing strain from climate change, aging populations, and geopolitical instability. The response is shifting from national regulation to transnational cooperation within multistakeholder fora.

We help clients anticipate these shifts, ensuring their commercial objectives align with Global Health Security priorities and Sustainable Development Goals (SDGs).

Our Network

Reverdin Consulting operates as a strategic hub, activating a curated network of Senior Advisors to match the specific granularity of your challenges. Our ecosystem spans former diplomats, scientific opinion leaders, and former government officials based in key jurisdictions—from the regulatory corridors of Brussels to the health ministries of the Global South. This agile structure allows us to assemble bespoke task forces that combine technical depth with the political acumen required to navigate the highest levels of international governance.

Focus Areas

Where we concentrate our sector expertise

Brain Health & Neuroscience Policy

With 3.4 billion people affected globally, neurological and mental health conditions are the next frontier of global health. We position clients as leaders in the Brain Economy. We build coalitions to elevate brain health on the G7/G20 agenda, advocating for integrated care models and robust funding for psychiatric and neurodegenerative research.

Innovative Health Financing

The 'investment gap' in global health threatens the deployment of new therapies. We bridge the gap between private innovation and public capital. We advise on blended finance models and engage with international financial institutions (World Bank, regional development banks) to unlock long-term resources for health infrastructure and R&D.

Translating Innovation into Impact

We advise pharmaceutical clients on market access strategies that go beyond pricing to address foundational health system gaps. We facilitate government partnerships that strengthen diagnostic infrastructure, clinical workforce, and care integration—creating the conditions for successful therapy adoption.

Our Approach

How we deliver results in this sector

Strategic Mapping

Identifying the most relevant multilateral platforms (WEF, UNGA, WHS) and institutional actors (WHO, UNICEF) for your therapeutic areas.

Coalition Building

Designing and managing public-private partnerships (PPPs) that serve as normative incubators—similar to the models of Gavi or the Paris Call—to set new industry standards.